News | March 11, 2023
Marksans Pharma announces USFDA approval for Famotidine Tablets
Marksans' OTC Famotidine Tablets USP are acid reducers
Marksans' OTC Famotidine Tablets USP are acid reducers
Chronic Kidney Disease is a growing epidemic with 850 million people affected worldwide.
IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases
The Development Center with its state-of-the art laboratories and flexible pilot capacities is set to become Siegfried's global research and development hub for its Drug Products sites, strengthening the global network
Ashland’s pharmaceutical business is well known for acetylenics, cellulosics, and film coatings
The new powder flow tester can characterize powder flow properties, offering valuable insight for pharmaceutical processing and formulation
With this additional route of administration, the MMRV Family now joins other routinely recommended vaccines that can be administered intramuscularly
These patches can be used in settings where patients need close vital signs monitoring, including cardiac rhythm.
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
Rocuronium Bromide Injection is a neuromuscular blocking agent
Subscribe To Our Newsletter & Stay Updated
